All AI news
AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D - MedCity News
0
A biotech startup raised $150 million to use AI to discover new drugs faster. This could eventually affect everyday people by speeding up medicine development, though results are years away.
Read the full article Discussion